Literature DB >> 24913467

Dosimetric comparison of IMRT rectal and anal canal plans generated using an anterior dose avoidance structure.

Brian Leicher1, Ellen Day2, Athanasios Colonias3, Olivier Gayou3.   

Abstract

To describe a dosimetric method using an anterior dose avoidance structure (ADAS) during the treatment planning process for intensity-modulated radiation therapy (IMRT) for patients with anal canal and rectal carcinomas. A total of 20 patients were planned on the Elekta/CMS XiO treatment planning system, version 4.5.1 (Maryland Heights MO) with a superposition algorithm. For each patient, 2 plans were created: one employing an ADAS (ADAS plan) and the other replanned without an ADAS (non-ADAS plan). The ADAS was defined to occupy the volume between the inguinal nodes and primary target providing a single organ at risk that is completely outside of the target volume. Each plan used the same beam parameters and was analyzed by comparing target coverage, overall plan dose conformity using a conformity number (CN) equation, bowel dose-volume histograms, and the number of segments, daily treatment duration, and global maximum dose. The ADAS and non-ADAS plans were equivalent in target coverage, mean global maximum dose, and sparing of small bowel in low-dose regions (5, 10, 15, and 20 Gy). The mean difference between the CN value for the non-ADAS plans and ADAS plans was 0.04 ± 0.03 (p < 0.001). The mean difference in the number of segments was 15.7 ± 12.7 (p < 0.001) in favor of ADAS plans. The ADAS plan delivery time was shorter by 2.0 ± 1.5 minutes (p < 0.001) than the non-ADAS one. The ADAS has proven to be a powerful tool when planning rectal and anal canal IMRT cases with critical structures partially contained inside the target volume.
Copyright © 2014 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conformal dose; Dose avoidance structures; IMRT; Normal tissue sparing

Mesh:

Year:  2014        PMID: 24913467     DOI: 10.1016/j.meddos.2014.05.001

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  2 in total

1.  Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer.

Authors:  Ryuta Hirai; Tomoaki Tamaki; Mitsunobu Igari; Y U Kumazaki; Shin-Ei Noda; Shingo Kato
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  Half-beam volumetric-modulated arc therapy in adjuvant radiotherapy for gynecological cancers.

Authors:  Pei-Chieh Yu; Ching-Jung Wu; Hsin-Hua Nien; Louis Tak Lui; Suzun Shaw; Yu-Lun Tsai
Journal:  J Appl Clin Med Phys       Date:  2021-11-16       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.